Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
DNAKE Emerges as a Global Innovator in Brain-Computer Interface Technology 2025-07-18 16:19
MFDS Clears DeepQure's HyperQure™ for Clinical Trial in Atrial Fibrillation 2025-07-18 10:59
Co-PSMA trial: Recruitment successfully completed 2025-07-17 21:01
SK bioscience Submits IND for Phase 1/2 Clinical Trial of Adjuvanted Influenza Vaccine Candidate 2025-07-17 19:00
GC Biopharma Receives Marketing Authorization for BARYCELA in Vietnam 2025-07-17 13:56
Unlocking New Opportunities in Asia and the Greater Bay Area 2025-07-17 09:55
Nature Medicine Published Phase 1 Results of Innovent Biologics' Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma 2025-07-17 08:00
Flat Medical Honored at Premier, Inc.'s Annual Supplier Innovation Celebration 2025-07-16 21:30
SNB-101 Earns Government Backing as Promising Therapy for Small Cell Lung Cancer 2025-07-16 20:00
WuXi Biologics Granted Highest Negligible-Risk ESG Rating from Morningstar Sustainalytics 2025-07-16 18:00
Senhwa Biosciences announces first patient dosed in NCI-sponsored pilot study of Pidnarulex (CX-5461) pharmacodynamics in patients with advanced solid tumors 2025-07-16 10:32
Akeso Announces First Patient Enrolled in the Phase III Trial（AK112-312/HARMONi-GI6）of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer 2025-07-16 09:47
Avio Health Launches AI Platform to Turn Disconnected Health Data into Preventive Intelligence 2025-07-15 21:41
Introducing the VARON VP-8G: A Smarter, Lighter Portable Oxygen Concentrator Built for Life on the Move 2025-07-15 20:25
OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company 2025-07-15 19:30
Baraya Extended Care Closes Series B Funding Round Bringing Total Capital Raised to USD 124 Million from TVM Capital Healthcare and a Syndicate of Prominent Investors 2025-07-15 14:00
Ascletis Completes Dosing of All Participants in Its U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity 2025-07-15 07:00
Concord Healthcare Announces Completion of China's First Proton Therapy for Choroidal Malignant Melanoma 2025-07-15 04:05
Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform 2025-07-14 15:38
CARsgen Successfully Defends Its GPC3 CAR-T Patent at the EPO 2025-07-14 08:00
1 22 23 24 25 26 491